This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Discussing the potential of Pulse Biosciences' CellFX nanosecond pulsed field ablation (nsPFA) system for atrial fibrillation

Ticker(s): PLSE, BSX, MDT, ABT, JNJ

Who's the expert?

Institution: UC Health

  • Clinical Cardiac Electrophysiology at UC Health 
  • Has performed over 50 Pulsed Field Abaltion Cases on various systems
  • Research Interest in monitoring and diagnosing atrial fibrillation and is a consultant for both Abbott and Medtronic

Interview Questions
Q1.

Please describe your background and practice setting

Added By: ben_admin
Q2.

How many patients with heart arrhythmia do you manage?

Added By: ben_admin
Q3.

What patients do you consider PFA treatment for?

Added By: ben_admin
Q4.

How are current PFA systems different from one another?

Added By: ben_admin
Q5.

Do you see the usage of PFAs increasing?

Added By: ben_admin
Q6.

What are your thoughts on Pulse Biosciences PFA system?

Added By: ben_admin

Are You Interested In These Questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.